Cargando…
Trends in Use, Cost, and Outcomes of Human Recombinant Erythropoietin, 1989-98
In this article the authors present descriptive data showing trends in human recombinant erythropoietin (EPO) doses, charges, and patient hematocrits from the fourth quarter of calendar year 1989 to the first quarter of 1998 for all recipients and recent data for patients treated by in-center hemodi...
Autores principales: | Greer, Joel W., Milam, Roger A., Eggers, Paul W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
CENTERS for MEDICARE & MEDICAID SERVICES
1999
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4194623/ https://www.ncbi.nlm.nih.gov/pubmed/10558020 |
Ejemplares similares
-
A Review of the First Year of Medicare Coverage of Erythropoietin
por: Griffiths, Robert I., et al.
Publicado: (1994) -
Trends in the Treatment of Anemia Using Recombinant Human Erythropoietin in Patients with HIV Infection
por: Sullivan, Patrick S, et al.
Publicado: (2011) -
Cost-effectiveness of recombinant human erythropoietin in the prevention of chemotherapy-induced anaemia.
por: Barosi, G., et al.
Publicado: (1998) -
The Clinical Impact of Recombinant Human Erythropoietin
por: Muirhead, N
Publicado: (1997) -
Comparison of Oral Recombinant Erythropoietin and Subcutaneous Recombinant Erythropoietin in Prevention of Anemia of Prematurity
por: Saeidi, R, et al.
Publicado: (2012)